Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis

Abstract

The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac). Sera of 202 systemiclupus erythematosus(SLE) patients, 33 patients suffering from other autoimmune diseases and 115 healthy blood donors were analysed for anti-dsDNA antibodies by IgG-, IgA- and IgM-specific ELISA, Farr-assay and CLIF. A subset of 24 SLE patients was investigated in a longitudinal study over a period of one to six years. Disease activity of 105 SLE patients was measured according to the ECLAM score. In the cohort of SLE patients 63% were positivefor the IgG class, 40% for the IgA and 57% for the IgM class specific anti-dsDNA ELISA. Sensitivity (79%) and specificity (99%) for the diagnosis of SLE appeared to be highest for the ELISA measuring all isotypes of anti-dsDNA antibodies. The concentrations of anti- dsDNA isotypesshowed a strong correlationwith disease activity. Analysing the relationship between IgG, IgA and IgM anti-dsDNA antibody isotypes and clinical manifestation, we found a significant associationof the IgM isotypewith cutaneousinvolvementand of the IgG isotypewith lupus nephritis. The IgG/IgM ratio of anti-dsDNA antibodies represented a significant parameter to distinguish patients with lupus nephritis from those without renal involvement. In the longitudinal study, a continuous ratio under 0.8 was associated with absence of renal involvement throughout the investigatedperiod. In conclusion, the evaluationof anti-dsDNA isotypesprovidesa diagnostictool to define subsets within SLE patients with different clinical manifestations. In particular, the IgG/IgM ratio of anti-dsDNA antibodies could be used as a prognostic marker for lupus nephritis during the course of the disease.

Keywords

anti-dsDNA antibodies immunoglobuline isotypes lupus nephritis SLE

Get full access to this article

View all access options for this article.

References

Quismorio FP Jr. Clinical application of serologic abnormilaties in systemic lupus erythematosus. In: Wallace DJ , Hahn BH (ed). Dubois’ Lupus Erythematosus. Baltimore: Williams & Wilkins , 1997, 925-942.

Smeenk R , Hykema M. Detection of antibodies to DNA: a technical assessment . Mol Biol Rep 1992; 17: 71-79 .

Brinkman K , Brink H , Van der Swaak AJG. A comparison of assays used for the detection of antibodiesto DNA . Clin Rheumatol 1990;9 (Suppl1): 63-73 .

Okamura M , Kanayama Y , Amastu K et al. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology . Ann Rheum Dis 1993; 52: 14-20 .

Hahn BH. Antibodies to DNA . N Engl J Med 1998; 338(19): 1359-1368 .

Bootsma H , Spronk PE , Hummel EJ et al. Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM class antibodies . Scand J Rheumatol 1996; 25: 352-429 .

Pankewycz, OG , Migliorini P , Madaio MP. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis . J Immunol 1987; 139: 3287-3294 .

Vitali C , Bendivelli W , Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the consensus study group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score . Clin Exp Rheumatol 1992; 10: 541-547 .

Mosca M , Bencivelli W , Vitali C , Carrai P , Neri R , Bombardieri S. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus . Lupus 2000; 9: 445-450 .

10.

Wiegand R , Gottschalk R , Falkenbach A , Matthias T , Kaltwasser JP , Hoelzer D. Evaluation of diagnostic efficiency of three different antigens for the development of a highly specific anti-dsDNA ELISA for the diagnosisof systemic lupus erythematosus in comparison to the Crithidia luciliae immunofluorescence test . Z Rheumatol 1997; 56: 53-62 .

11.

Feltkamp TEW. Standards for ANA and anti-DNA . Clin Rheumatol 1990; 24: 146-153 .

12.

Helmke K , Schaeben B , Federlin K. Measurement of DNA antibodies in patients with SLE and other autoimmune diseases using various techniques . Ann Rheum Dis 1977; 36 (Suppl): 96-101 .

13.

Tron F , Bach JF. Relationship between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus . Clin Exp Immunol 1977; 28: 426-432 .

14.

Leon SA , Green A , Ehrlich GE , Polard M , Shapiro B. Avidity of antibodies in SLE: relation to severity of renal involvement . Arthitis Rheum 1977; 20: 23-29 .

15.

Smeenk RJT , Lelij G , Swaak AJG , Groenwold J , Aarden LA. Specificity in SLE antibodies to dsDNA measured with the PEG-assay . Arthritis Rheum 1982; 25: 631-638 .

16.

Witte T , Hartung K , Matthias T , Sachse C , Fricke M , Deichler H et al. SLE study group . Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus . Rheumatol Int 1998; 18(2): 63-69 .

17.

Krippner H , Merle S , Jörgens K , Pirlet K. Antibodies to dsDNA and ssDNA in the immunglobulin classes IgG and IgM: prognostic value in the course of SLE . Z Rheumatol 1984; 43: 265-271 .

18.

Pennebaker JB , Gilliam JN , Ziff M. Immunglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus . J Clin Invest 1977; 60: 1331-1338 .

19.

Smeenk R , Van Rooyen A , Swaak AJG. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity . J Immunol Methods 1988; 109(1): 27-35 .

20.

Winfield JB , Feiferman I , Koffler D. Aviditiy of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus: association of high avidity antinative DNA antibody with glomerulonephritis . J Clin Invest 1977; 59: 90-96 .

21.

Witte T , Hartung K , Sachse C et al. IgM anti-dsDNA antobodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group . Rheumatol Int 1998; 18(3): 85-91 .

22.

Sontheimer RD , Gilliam JN. DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis . Clin Immunol Immunopathol 1978; 10: 459-467 .

23.

Koffler D , Agnello V , Kunkel H. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus . Am J Pathol 1974; 74: 109-122 .

24.

D’Andrea DM , Coupaye-Gerard B , Kleyman TR , Foster MH , Madaio MP. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens . Kidney Int 1996; 49: 1214-1221 .

25.

Faaber P , Capel PJA , Rijke GPM. Cross-reactivity of anti-DNA antibodies with proteoglycans . Clin Exp Immunol 1984; 55: 502-510 .

26.

Putterman C , Limpanasithkul W , Edelman M , Diamond B. The double edge sword of the immune response: mutational analysis of a murine anti-pneumococcal anti-DNA antibody . J Clin Invest 1996; 97: 2251-2259 .

27.

Termaat RM , Assmann KJM , Dijkman HPM , Smeenk RJT , Berden JHM. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms . Kidney Int 1992; 42: 1363-1371 .

28.

Ehrenstein MR , Katz DR , Griffiths MH et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice . Kidney Int 1995; 48: 705-711 .

29.

Manger K , Manger B , Repp R , Geisselbrecht M , Geiger A , Pfahlberg A et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus . Ann Rheum Dis 2002, 61: 1065-1070 .

30.

Zabaleta-Lanz M , Vargas-Arenas R , Tapanes F , Daboin I , Pinto J , Bianco NE. Silent nephritis in systemic lupus erythematosus . Lupus 2001; 10: 17-17 .